Pedro A Lamothe

Sep 27, 2024 | nature.com | Doan C. Nguyen |Natalie Haddad |Pedro A Lamothe |Ignacio Sanz

AbstractSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccines are effective at protecting from severe disease, but the protective antibodies wane rapidly even though SARS-CoV-2-specific plasma cells can be found in the bone marrow (BM).

Sep 2, 2024 | sciencedirect.com | Pedro A Lamothe |F. Eun-Hyung Lee |Debra J. Palmer |Susan L. Prescott

Supported by the (grant K23 AI163371 [to L.L.]. Disclosure of potential conflict of interest: K. G. Blumenthal receives grant support from the Agency for Healthcare Research and Quality (grant R01 HS029319) and the National Institutes of Health (grant U01 AI184071), prior grant support from Phadia Ab (Thermo Fisher Scientific), and royalties from UpToDate, outside of the submitted work. The remaining author declares that she has no relevant conflicts of interest.